| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2265.2002.01654.X |
| P698 | PubMed publication ID | 12390330 |
| P50 | author | Ponnusamy Saravanan | Q40998198 |
| Colin M Dayan | Q42533527 | ||
| Kavita Vedhara | Q50553213 | ||
| Rosemary Greenwood | Q70176470 | ||
| P2093 | author name string | N Roberts | |
| W-F Chau | |||
| P2860 | cites work | Thyroid function tests-time for a reassessment | Q33817000 |
| The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey | Q34328733 | ||
| Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism | Q34491897 | ||
| The replacement therapy problem in hypothyroidism | Q39559881 | ||
| Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications | Q40126686 | ||
| Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones | Q40320485 | ||
| Thyroxine should be tried in clinically hypothyroid but biochemically euthyroid patients | Q42784015 | ||
| Identification of a thyroid hormone receptor that is pituitary-specific | Q44748833 | ||
| Weight gain following treatment of hyperthyroidism | Q47203252 | ||
| A study of mental morbidity among primary care patients in Nigeria | Q47272679 | ||
| Regulation of thyroxine 5'-deiodinase activity by 3,5,3'-triiodothyronine in cultured rat anterior pituitary cells | Q48653158 | ||
| Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. | Q50603948 | ||
| The validity of two versions of the GHQ in the WHO study of mental illness in general health care. | Q50959565 | ||
| Multiple applications of the GHQ-12 in a general population sample: an investigation of long-term retest effects. | Q51969778 | ||
| ??? | Q24655194 | ||
| P433 | issue | 5 | |
| P921 | main subject | questionnaire | Q747810 |
| P304 | page(s) | 577-585 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Clinical Endocrinology | Q15762781 |
| P1476 | title | Psychological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study | |
| P478 | volume | 57 |
| Q22306402 | 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism |
| Q30989378 | A biopsychosocial approach to primary hypothyroidism: treatment and harms data from a randomized controlled trial |
| Q44850438 | A combination of T3, and T4 for hypothyroidism? |
| Q57283984 | A decade of thyroidology |
| Q34831621 | A meta-analysis of the associations between common variation in the PDE8B gene and thyroid hormone parameters, including assessment of longitudinal stability of associations over time and effect of thyroid hormone replacement |
| Q46884216 | Acquired hypothyroidism after switching from thyroid USP to levothyroxine |
| Q61812235 | Adjuvant rituximab, a potential treatment for the young patient with Graves' hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial |
| Q52604785 | An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction. |
| Q33561107 | Applying a systems approach to thyroid physiology: Looking at the whole with a mitochondrial perspective instead of judging single TSH values or why we should know more about mitochondria to understand metabolism |
| Q35205079 | Clinical scoring scales in thyroidology: A compendium |
| Q36317639 | Clinical, behavioural and pharmacogenomic factors influencing the response to levothyroxine therapy in patients with primary hypothyroidism-protocol for a systematic review. |
| Q89359063 | Cognitive functioning and quality of life in patients with Hashimoto thyroiditis on long-term levothyroxine replacement |
| Q98177571 | Combination Therapy for Hypothyroidism: Rationale, Therapeutic Goals, and Design |
| Q46884214 | Combination therapy in a hypothyroid patient intolerant of elevated thyroxine |
| Q39623711 | Comparative study between the effects of replacement therapy with liquid and tablet formulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients |
| Q47829069 | Concurrent Hypoparathyroidism Is Associated With Impaired Physical Function and Quality of Life in Hypothyroidism. |
| Q42546587 | Concurrent administration of thyroxine and donepezil induces plastic changes in the prefrontal cortex of adult hypothyroid rats |
| Q48142406 | Current evidence for the treatment of hypothyroidism with levothyroxine/levotriiodothyronine combination therapy versus levothyroxine monotherapy. |
| Q41634990 | Current recommendations in the management of hypothyroidism: developed from a statement by the British Thyroid Association Executive |
| Q37020034 | Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive Parameters |
| Q48095468 | Depressive symptoms in patients with subclinical hypothyroidism--the effect of treatment with levothyroxine: a double-blind randomized clinical trial |
| Q92132500 | Design of the Optimal Trial of Combination Therapy |
| Q48714806 | Deteriorated executive functions in patients with successful surgery for pituitary adenomas compared with other chronically ill patients |
| Q36039289 | Disease-Specific as Well as Generic Quality of Life Is Widely Impacted in Autoimmune Hypothyroidism and Improves during the First Six Months of Levothyroxine Therapy |
| Q41105417 | Dual control of pituitary thyroid stimulating hormone secretion by thyroxine and triiodothyronine in athyreotic patients |
| Q39659704 | Effect of Thyroid Function Variations Within the Laboratory Reference Range on Health Status, Mood, and Cognition in Levothyroxine-Treated Subjects |
| Q55365577 | Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life. |
| Q34673332 | Effects of thyroxine and donepezil on hippocampal acetylcholine content, acetylcholinesterase activity, synaptotagmin-1 and SNAP-25 expression in hypothyroid adult rats |
| Q43287332 | Efficacy of combined levothyroxine and liothyronine as compared with levothyroxine monotherapy in primary hypothyroidism: a randomized controlled trial. |
| Q51839558 | Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): an initial examination. |
| Q41905202 | European thyroid association guidelines on L-t4 + L-t3 combination for hypothyroidism: a weary step in the right direction |
| Q47552115 | Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients. |
| Q50618911 | Exploring the experiences of people with hypo- and hyperthyroidism. |
| Q43436546 | Gender differences in symptoms of hypothyroidism: a population-based DanThyr study |
| Q28649731 | Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement |
| Q38635784 | Hypothyroid Patients Encoding Combined MCT10 and DIO2 Gene Polymorphisms May Prefer L-T3 + L-T4 Combination Treatment - Data Using a Blind, Randomized, Clinical Study. |
| Q56566105 | Hypothyroidism |
| Q37519042 | Hypothyroidism after a cancer diagnosis: etiology, diagnosis, complications, and management |
| Q90729561 | Hypothyroidism and Cognitive Disorders during Development and Adulthood: Implications in the Central Nervous System |
| Q33597605 | Hypothyroidism and depression |
| Q36016684 | Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment. |
| Q30235120 | Hypothyroidism. |
| Q57792487 | Identification of Primary Medication Concerns Regarding Thyroid Hormone Replacement Therapy From Online Patient Medication Reviews: Text Mining of Social Network Data |
| Q35878274 | Identifying a Small Molecule Blocking Antigen Presentation in Autoimmune Thyroiditis |
| Q96231047 | Importance of Thyroid Hormone level and Genetic Variations in Deiodinases for Patients after Acute Myocardial Infarction: A Longitudinal Observational Study |
| Q59441952 | Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing |
| Q34396487 | Increased risk of long-term sickness absence, lower rate of return to work, and higher risk of unemployment and disability pensioning for thyroid patients: a Danish register-based cohort study |
| Q36338684 | Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: a systematic qualitative review |
| Q33469937 | Insulin Plant (Costus pictus) Extract Restores Thyroid Hormone Levels in Experimental Hypothyroidism |
| Q37290903 | Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism? |
| Q39325007 | Is a Normal TSH Synonymous With "Euthyroidism" in Levothyroxine Monotherapy? |
| Q97421049 | LT4 and Slow Release T3 Combination: Optimum Therapy for Hypothyroidism? |
| Q93113099 | Levothyroxine Dose Adjustment to Optimise Therapy Throughout a Patient's Lifetime |
| Q33988437 | Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients |
| Q90708234 | Liothyronine cost and prescriptions in England |
| Q48155725 | Management of hypothyroidism with combination thyroxine (T4) and triiodothyronine (T3) hormone replacement in clinical practice: a review of suggested guidance |
| Q38502679 | Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee. |
| Q38804128 | Maturation in serum thyroid function parameters over childhood and puberty: results of a longitudinal study |
| Q34210538 | Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine |
| Q27687147 | Molecular markers in the diagnosis of thyroid nodules |
| Q91644250 | Mood Disorders in Levothyroxine-Treated Hypothyroid Women |
| Q96132250 | Negative illness perceptions are related to poorer health-related quality of life among thyroid cancer survivors: Results from the PROFILES registry |
| Q34175641 | New insights into thyroid hormone replacement therapy |
| Q90290390 | Novel Insight Into the Epigenetic and Post-transcriptional Control of Cardiac Gene Expression by Thyroid Hormone |
| Q37437148 | Novel insights into thyroid hormones from the study of common genetic variation |
| Q49718989 | Older patients' experience of primary hypothyroidism: A qualitative study |
| Q47108663 | Optimal Levothyroxine Replacement Adequately Improves Symptoms of Hypothyroidism; Residual Symptoms Need Further Evaluation for Other than Hypothyroidism Causation |
| Q41684030 | Out-of-Reference Range Thyroid-Stimulating Hormone Levels in Levothyroxine-Treated Primary Hypothyroid Patients: A Multicenter Observational Study |
| Q38178080 | Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism |
| Q57136461 | Pathophysiological relevance of deiodinase polymorphism |
| Q37074300 | Patient-reported outcomes in adequately treated hypothyroidism - insights from the German versions of ThyDQoL, ThySRQ and ThyTSQ |
| Q90625310 | Patients' attitudes and perceptions towards treatment of hypothyroidism in general practice: an in-depth qualitative interview study |
| Q38668982 | Persistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level |
| Q48072337 | Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly |
| Q51317445 | Prevalence of Dio2(T92A) polymorphism and its association with thyroid autoimmunity. |
| Q44404334 | Prevalence of treated hypothyroidism in the adult population |
| Q34688130 | Psychiatric and cognitive manifestations of hypothyroidism |
| Q44514175 | Psychological well-being of patients on L-thyroxine |
| Q44186995 | Psychological wellbeing in patients |
| Q40077839 | Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review |
| Q48505045 | Recent Advances in Thyroid Hormone Regulation: Toward a New Paradigm for Optimal Diagnosis and Treatment. |
| Q39544905 | Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association |
| Q38918802 | Reference values for TSH may be inadequate to define hypothyroidism in persons with morbid obesity: Di@bet.es study. |
| Q93189112 | Relationship of Physicians' Rapport with Patients' Satisfaction and Psychological Well-being During Hospitalization |
| Q34323022 | Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism |
| Q38823533 | Risks and safety of combination therapy for hypothyroidism |
| Q26785400 | Scope and limitations of iodothyronine deiodinases in hypothyroidism |
| Q52591847 | Serum microRNA profiles in athyroid patients on and off levothyroxine therapy. |
| Q49616776 | Shift From Levothyroxine Tablets To Liquid Formulation At Breakfast Improves Quality Of Life Of Hypothyroid Patients |
| Q57828025 | Short-term Withdrawal of Levothyroxine, Induced Increase of Thyroid-stimulating Hormone and an Increase Ratio of Triiodothyronine to Thyroxine |
| Q25471519 | Structural and functional MRI study of the brain, cognition and mood in long-term adequately treated Hashimoto's thyroiditis |
| Q34585419 | Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone |
| Q92921594 | Sustained Release T3 Therapy: Animal Models and Translational Applications |
| Q58339026 | Systemic Thyroid Hormone Status During Levothyroxine Therapy In Hypothyroidism: A Systematic Review and Meta-Analysis |
| Q93052630 | Systemic Thyroid Hormone Status in Treated Graves' Disease |
| Q36363046 | T3 and T4: are we missing half the picture? |
| Q90738089 | T4 + T3 combination therapy: any progress? |
| Q41525195 | TSH cut off point based on depression in hypothyroid patients |
| Q92138579 | The Effect of COVID-19 on Youth Mental Health |
| Q42667837 | The Effect of Daily versus Weekly Levothyroxine Replacement on Thyroid Function Test in Hypothyroid Patients at a Tertiary Care Centre in Haryana |
| Q22305294 | The History and Future of Treatment of Hypothyroidism |
| Q35636334 | The Link between Thyroid Function and Depression |
| Q92238770 | The Swinging Pendulum in Treatment for Hypothyroidism: From (and Toward?) Combination Therapy |
| Q37702377 | The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial |
| Q37778756 | The difficult patient: drug interaction and the influence of concomitant diseases on the treatment of hypothyroidism |
| Q37616843 | The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition |
| Q39040887 | The emergence of levothyroxine as a treatment for hypothyroidism |
| Q34544949 | The homeostatic set point of the hypothalamus-pituitary-thyroid axis--maximum curvature theory for personalized euthyroid targets. |
| Q34351047 | The influence of a biopsychosocial-based treatment approach to primary overt hypothyroidism: a protocol for a pilot study. |
| Q33925748 | The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients |
| Q35830724 | The ratio of serum free triiodothyronine to free thyroxine in children: a retrospective database survey of healthy short individuals and patients with severe thyroid hypoplasia or central hypothyroidism. |
| Q36361581 | The relationship of 19 functional polymorphisms in iodothyronine deiodinase and psychological well-being in hypothyroid patients |
| Q26765098 | Thyroid Hormone Replacement in Patients Following Thyroidectomy for Thyroid Cancer |
| Q44694797 | Thyroid function is associated with presence and severity of coronary atherosclerosis. |
| Q42781540 | Thyroid function tests and hypothyroidism |
| Q39769201 | Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer. |
| Q37290881 | Thyroid hormone replacement therapy: three 'simple' questions, complex answers |
| Q37901475 | Thyroid hormone replacement: current status and challenges. |
| Q35789443 | Thyroid-specific questions on work ability showed known-groups validity among Danes with thyroid diseases |
| Q90219094 | Thyrotoxicosis after massive triiodothyronine (LT3) overdose: a coast-to-coast case series and review |
| Q38820336 | Thyroxine replacement: a clinical endocrinologist's viewpoint. |
| Q92815592 | To Treat or Not to Treat Subclinical Hypothyroidism, What Is the Evidence? |
| Q35673053 | Treated Autoimmune Thyroid Disease Is Associated with a Decreased Quality of Life among Young Persons with Type 1 Diabetes. |
| Q22305857 | Treatment for primary hypothyroidism: current approaches and future possibilities |
| Q34997537 | Type and extent of somatic morbidity before and after the diagnosis of hypothyroidism. a nationwide register study |
| Q34150293 | Whose normal thyroid function is better--yours or mine? |
| Q35205088 | Why are our hypothyroid patients unhappy? Is tissue hypothyroidism the answer? |
| Q37834723 | Wound complications in thyroxine-supplemented patients following foot and ankle surgery |
Search more.